Latest News on Lupin
Showing of 0 - 10 from 96 results
Lupin - Total results - 96
Feb 19, 2020
Power sector stress spreads to new areas, corporate India’s poor Q3 numbers just a trailer; all this and more on Moneycontrol ProThe Ujwal Discom Assurance Yojana (UDAY), which was launched more than four years ago, has failed to revive the electricity distribution sector to the desired strength.
Feb 03, 2020
Budget overhang, RBI policy, third quarter earnings to decide market course this week; investors disappointed: AnalystsGiving a thumbs down to the Budget, the market benchmark Sensex logged its biggest single-day plunge in more than a decade on Saturday after Budget presentation.
Nov 11, 2019
Lupin to divest entire stake in Japanese subsidiary Kyowa Pharma to PE fund Unison Capital Partners for over Rs 3,702 crUnder the terms of agreement, Lupin's subsidiary Nanomi BV will divest its entire stake in Kyowa to Unison's entity Plutus Ltd for an enterprise value of JPY 57,361
May 27, 2019
Lupin shares fall 2.5% after USFDA says Goa facility may be subject to regulatory actionThe scrip declined 2.49 percent to close at Rs 743.95 on the BSE. During the day, it dropped 5.43 percent to Rs 721.50
May 08, 2019
Lupin gets more time from govt to complete project in Indore SEZ; vows to begin production before March 2020Lupin is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations metered dose inhalers and dry powder inhalers.
Apr 18, 2019
Lupin seeks more time from govt to complete project in Indore SEZ; board of approval to take up matter on 22 AprilLupin received the LoP on 12 April, 2016. It has already received two extensions, valid till 11 April this year.
Feb 06, 2019
Lupin reports Rs 152 cr loss in Q3 on one-time provisioning for litigation expenses; income from operations riseOn 12 December, 2018, the General Court of the European Union delivered its judgment concerning Lupin's appeal against the European Commission's 2014 decision in a litigation related to Perindopril.
Dec 10, 2018
Lupin gets Establishment Inspection Report from USFDA for Pithampur facility unit; stock falls 1.88%Drug firm Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for a unit of its Pithampur facility in Madhya Pradesh.
Nov 27, 2018
Lupin gets observation in establishment inspection report from USFDA for Tarapur facilityShares of Lupin were trading at Rs 854.00 per scrip on the BSE, up 1.09 percent from its previous close.
Aug 24, 2018
Lupin gets establishment inspection report from USFDA for its Nagpur facilityEarlier in May, in a regulatory filing Lupin had said that the US health regulator had completed inspection of the Nagpur facility without making any observations.